The global market for Mesalazine API was estimated to be worth US$ 161.9 million in 2023 and is forecast to a readjusted size of US$ 224 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Mesalazine API - Market

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalazine API by region & country, by Type, and by Application.

The Mesalazine API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine API.

Market Segmentation

Scope of Mesalazine API - Market Report

Report Metric	Details
Report Name	Mesalazine API - Market
Forecasted market size in 2030	US$ 224 million
CAGR	3.7%
Forecasted years	2024 - 2030
Segment by Type:	Above 97 % Above 98 % Above 99 %
Segment by Application	Tablets Capsules Granule Suppository Enema Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mesalazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mesalazine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Mesalazine API - Market size in 2030?

Ans: The Mesalazine API - Market size in 2030 will be US$ 224 million.

Who are the main players in the Mesalazine API - Market report?

Ans: The main players in the Mesalazine API - Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalazine API - Market report?

Ans: The Applications covered in the Mesalazine API - Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalazine API - Market report?

Ans: The Types covered in the Mesalazine API - Market report are Above 97 %, Above 98 %, Above 99 %

1 Market Overview

1.1 Mesalazine API Product Introduction

1.2 Global Mesalazine API Market Size Forecast

1.2.1 Global Mesalazine API Sales Value (2019-2030)

1.2.2 Global Mesalazine API Sales Volume (2019-2030)

1.2.3 Global Mesalazine API Sales Price (2019-2030)

1.3 Mesalazine API Market Trends & Drivers

1.3.1 Mesalazine API Industry Trends

1.3.2 Mesalazine API Market Drivers & Opportunity

1.3.3 Mesalazine API Market Challenges

1.3.4 Mesalazine API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mesalazine API Players Revenue Ranking (2023)

2.2 Global Mesalazine API Revenue by Company (2019-2024)

2.3 Global Mesalazine API Players Sales Volume Ranking (2023)

2.4 Global Mesalazine API Sales Volume by Company Players (2019-2024)

2.5 Global Mesalazine API Average Price by Company (2019-2024)

2.6 Key Manufacturers Mesalazine API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Mesalazine API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Mesalazine API

2.9 Mesalazine API Market Competitive Analysis

2.9.1 Mesalazine API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Mesalazine API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Above 97 %

3.1.2 Above 98 %

3.1.3 Above 99 %

3.2 Global Mesalazine API Sales Value by Type

3.2.1 Global Mesalazine API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Mesalazine API Sales Value, by Type (2019-2030)

3.2.3 Global Mesalazine API Sales Value, by Type (%) (2019-2030)

3.3 Global Mesalazine API Sales Volume by Type

3.3.1 Global Mesalazine API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Mesalazine API Sales Volume, by Type (2019-2030)

3.3.3 Global Mesalazine API Sales Volume, by Type (%) (2019-2030)

3.4 Global Mesalazine API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Capsules

4.1.3 Granule

4.1.4 Suppository

4.1.5 Enema

4.1.6 Others

4.2 Global Mesalazine API Sales Value by Application

4.2.1 Global Mesalazine API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Mesalazine API Sales Value, by Application (2019-2030)

4.2.3 Global Mesalazine API Sales Value, by Application (%) (2019-2030)

4.3 Global Mesalazine API Sales Volume by Application

4.3.1 Global Mesalazine API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Mesalazine API Sales Volume, by Application (2019-2030)

4.3.3 Global Mesalazine API Sales Volume, by Application (%) (2019-2030)

4.4 Global Mesalazine API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Mesalazine API Sales Value by Region

5.1.1 Global Mesalazine API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Mesalazine API Sales Value by Region (2019-2024)

5.1.3 Global Mesalazine API Sales Value by Region (2025-2030)

5.1.4 Global Mesalazine API Sales Value by Region (%), (2019-2030)

5.2 Global Mesalazine API Sales Volume by Region

5.2.1 Global Mesalazine API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Mesalazine API Sales Volume by Region (2019-2024)

5.2.3 Global Mesalazine API Sales Volume by Region (2025-2030)

5.2.4 Global Mesalazine API Sales Volume by Region (%), (2019-2030)

5.3 Global Mesalazine API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Mesalazine API Sales Value, 2019-2030

5.4.2 North America Mesalazine API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Mesalazine API Sales Value, 2019-2030

5.5.2 Europe Mesalazine API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Mesalazine API Sales Value, 2019-2030

5.6.2 Asia Pacific Mesalazine API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Mesalazine API Sales Value, 2019-2030

5.7.2 South America Mesalazine API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Mesalazine API Sales Value, 2019-2030

5.8.2 Middle East & Africa Mesalazine API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mesalazine API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Mesalazine API Sales Value

6.2.1 Key Countries/Regions Mesalazine API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Mesalazine API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Mesalazine API Sales Value, 2019-2030

6.3.2 United States Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Mesalazine API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Mesalazine API Sales Value, 2019-2030

6.4.2 Europe Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Mesalazine API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Mesalazine API Sales Value, 2019-2030

6.5.2 China Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Mesalazine API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Mesalazine API Sales Value, 2019-2030

6.6.2 Japan Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Mesalazine API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Mesalazine API Sales Value, 2019-2030

6.7.2 South Korea Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Mesalazine API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Mesalazine API Sales Value, 2019-2030

6.8.2 Southeast Asia Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Mesalazine API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Mesalazine API Sales Value, 2019-2030

6.9.2 India Mesalazine API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Mesalazine API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 PharmaZell

7.1.1 PharmaZell Company Information

7.1.2 PharmaZell Introduction and Business Overview

7.1.3 PharmaZell Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 PharmaZell Mesalazine API Product Offerings

7.1.5 PharmaZell Recent Development

7.2 Syntese A/S

7.2.1 Syntese A/S Company Information

7.2.2 Syntese A/S Introduction and Business Overview

7.2.3 Syntese A/S Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Syntese A/S Mesalazine API Product Offerings

7.2.5 Syntese A/S Recent Development

7.3 Cambrex Corporation

7.3.1 Cambrex Corporation Company Information

7.3.2 Cambrex Corporation Introduction and Business Overview

7.3.3 Cambrex Corporation Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Cambrex Corporation Mesalazine API Product Offerings

7.3.5 Cambrex Corporation Recent Development

7.4 Divis Laboratories

7.4.1 Divis Laboratories Company Information

7.4.2 Divis Laboratories Introduction and Business Overview

7.4.3 Divis Laboratories Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Divis Laboratories Mesalazine API Product Offerings

7.4.5 Divis Laboratories Recent Development

7.5 Chemi SpA

7.5.1 Chemi SpA Company Information

7.5.2 Chemi SpA Introduction and Business Overview

7.5.3 Chemi SpA Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Chemi SpA Mesalazine API Product Offerings

7.5.5 Chemi SpA Recent Development

7.6 Ipca Laboratories

7.6.1 Ipca Laboratories Company Information

7.6.2 Ipca Laboratories Introduction and Business Overview

7.6.3 Ipca Laboratories Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Ipca Laboratories Mesalazine API Product Offerings

7.6.5 Ipca Laboratories Recent Development

7.7 Hangzhou Brother

7.7.1 Hangzhou Brother Company Information

7.7.2 Hangzhou Brother Introduction and Business Overview

7.7.3 Hangzhou Brother Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Hangzhou Brother Mesalazine API Product Offerings

7.7.5 Hangzhou Brother Recent Development

7.8 Lianyungang Fengheng Biopharm

7.8.1 Lianyungang Fengheng Biopharm Company Information

7.8.2 Lianyungang Fengheng Biopharm Introduction and Business Overview

7.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Lianyungang Fengheng Biopharm Mesalazine API Product Offerings

7.8.5 Lianyungang Fengheng Biopharm Recent Development

7.9 Lasa Loboratory

7.9.1 Lasa Loboratory Company Information

7.9.2 Lasa Loboratory Introduction and Business Overview

7.9.3 Lasa Loboratory Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Lasa Loboratory Mesalazine API Product Offerings

7.9.5 Lasa Loboratory Recent Development

7.10 Corden Pharma Bergamo

7.10.1 Corden Pharma Bergamo Company Information

7.10.2 Corden Pharma Bergamo Introduction and Business Overview

7.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Corden Pharma Bergamo Mesalazine API Product Offerings

7.10.5 Corden Pharma Bergamo Recent Development

7.11 Erregierre SpA

7.11.1 Erregierre SpA Company Information

7.11.2 Erregierre SpA Introduction and Business Overview

7.11.3 Erregierre SpA Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Erregierre SpA Mesalazine API Product Offerings

7.11.5 Erregierre SpA Recent Development

7.12 CTX Lifescience

7.12.1 CTX Lifescience Company Information

7.12.2 CTX Lifescience Introduction and Business Overview

7.12.3 CTX Lifescience Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.12.4 CTX Lifescience Mesalazine API Product Offerings

7.12.5 CTX Lifescience Recent Development

7.13 Ishita Active Pharma Ingredients

7.13.1 Ishita Active Pharma Ingredients Company Information

7.13.2 Ishita Active Pharma Ingredients Introduction and Business Overview

7.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Ishita Active Pharma Ingredients Mesalazine API Product Offerings

7.13.5 Ishita Active Pharma Ingredients Recent Development

7.14 YC Biotech (Jiangsu)

7.14.1 YC Biotech (Jiangsu) Company Information

7.14.2 YC Biotech (Jiangsu) Introduction and Business Overview

7.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.14.4 YC Biotech (Jiangsu) Mesalazine API Product Offerings

7.14.5 YC Biotech (Jiangsu) Recent Development

7.15 Xinxiang Tianfeng Fine Chemical

7.15.1 Xinxiang Tianfeng Fine Chemical Company Information

7.15.2 Xinxiang Tianfeng Fine Chemical Introduction and Business Overview

7.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Offerings

7.15.5 Xinxiang Tianfeng Fine Chemical Recent Development

8 Industry Chain Analysis

8.1 Mesalazine API Industrial Chain

8.2 Mesalazine API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Mesalazine API Sales Model

8.5.2 Sales Channel

8.5.3 Mesalazine API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

List of Tables

Table 1. Mesalazine API Market Trends

Table 2. Mesalazine API Market Drivers & Opportunity

Table 3. Mesalazine API Market Challenges

Table 4. Mesalazine API Market Restraints

Table 5. Global Mesalazine API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Mesalazine API Revenue Market Share by Company (2019-2024)

Table 7. Global Mesalazine API Sales Volume by Company (2019-2024) & (Tons)

Table 8. Global Mesalazine API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Mesalazine API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Mesalazine API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Mesalazine API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Mesalazine API

Table 13. Global Mesalazine API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Mesalazine API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Mesalazine API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Mesalazine API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Mesalazine API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Mesalazine API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Mesalazine API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)

Table 22. Global Mesalazine API Sales Volume by Type (2019-2024) & (Tons)

Table 23. Global Mesalazine API Sales Volume by Type (2025-2030) & (Tons)

Table 24. Global Mesalazine API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Mesalazine API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Mesalazine API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Mesalazine API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Mesalazine API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Mesalazine API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Mesalazine API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Mesalazine API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Mesalazine API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Mesalazine API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)

Table 34. Global Mesalazine API Sales Volume by Application (2019-2024) & (Tons)

Table 35. Global Mesalazine API Sales Volume by Application (2025-2030) & (Tons)

Table 36. Global Mesalazine API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Mesalazine API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Mesalazine API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Mesalazine API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Mesalazine API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Mesalazine API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Mesalazine API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Mesalazine API Sales Value by Region (2019-2024) & (%)

Table 44. Global Mesalazine API Sales Value by Region (2025-2030) & (%)

Table 45. Global Mesalazine API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030

Table 46. Global Mesalazine API Sales Volume by Region (2019-2024) & (Tons)

Table 47. Global Mesalazine API Sales Volume by Region (2025-2030) & (Tons)

Table 48. Global Mesalazine API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Mesalazine API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Mesalazine API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Mesalazine API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Mesalazine API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Mesalazine API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Mesalazine API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Mesalazine API Sales Volume, (2019-2024) & (Tons)

Table 56. Key Countries/Regions Mesalazine API Sales Volume, (2025-2030) & (Tons)

Table 57. PharmaZell Company Information

Table 58. PharmaZell Introduction and Business Overview

Table 59. PharmaZell Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. PharmaZell Mesalazine API Product Offerings

Table 61. PharmaZell Recent Development

Table 62. Syntese A/S Company Information

Table 63. Syntese A/S Introduction and Business Overview

Table 64. Syntese A/S Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Syntese A/S Mesalazine API Product Offerings

Table 66. Syntese A/S Recent Development

Table 67. Cambrex Corporation Company Information

Table 68. Cambrex Corporation Introduction and Business Overview

Table 69. Cambrex Corporation Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Cambrex Corporation Mesalazine API Product Offerings

Table 71. Cambrex Corporation Recent Development

Table 72. Divis Laboratories Company Information

Table 73. Divis Laboratories Introduction and Business Overview

Table 74. Divis Laboratories Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Divis Laboratories Mesalazine API Product Offerings

Table 76. Divis Laboratories Recent Development

Table 77. Chemi SpA Company Information

Table 78. Chemi SpA Introduction and Business Overview

Table 79. Chemi SpA Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Chemi SpA Mesalazine API Product Offerings

Table 81. Chemi SpA Recent Development

Table 82. Ipca Laboratories Company Information

Table 83. Ipca Laboratories Introduction and Business Overview

Table 84. Ipca Laboratories Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Ipca Laboratories Mesalazine API Product Offerings

Table 86. Ipca Laboratories Recent Development

Table 87. Hangzhou Brother Company Information

Table 88. Hangzhou Brother Introduction and Business Overview

Table 89. Hangzhou Brother Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Hangzhou Brother Mesalazine API Product Offerings

Table 91. Hangzhou Brother Recent Development

Table 92. Lianyungang Fengheng Biopharm Company Information

Table 93. Lianyungang Fengheng Biopharm Introduction and Business Overview

Table 94. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Lianyungang Fengheng Biopharm Mesalazine API Product Offerings

Table 96. Lianyungang Fengheng Biopharm Recent Development

Table 97. Lasa Loboratory Company Information

Table 98. Lasa Loboratory Introduction and Business Overview

Table 99. Lasa Loboratory Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Lasa Loboratory Mesalazine API Product Offerings

Table 101. Lasa Loboratory Recent Development

Table 102. Corden Pharma Bergamo Company Information

Table 103. Corden Pharma Bergamo Introduction and Business Overview

Table 104. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Corden Pharma Bergamo Mesalazine API Product Offerings

Table 106. Corden Pharma Bergamo Recent Development

Table 107. Erregierre SpA Company Information

Table 108. Erregierre SpA Introduction and Business Overview

Table 109. Erregierre SpA Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 110. Erregierre SpA Mesalazine API Product Offerings

Table 111. Erregierre SpA Recent Development

Table 112. CTX Lifescience Company Information

Table 113. CTX Lifescience Introduction and Business Overview

Table 114. CTX Lifescience Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. CTX Lifescience Mesalazine API Product Offerings

Table 116. CTX Lifescience Recent Development

Table 117. Ishita Active Pharma Ingredients Company Information

Table 118. Ishita Active Pharma Ingredients Introduction and Business Overview

Table 119. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. Ishita Active Pharma Ingredients Mesalazine API Product Offerings

Table 121. Ishita Active Pharma Ingredients Recent Development

Table 122. YC Biotech (Jiangsu) Company Information

Table 123. YC Biotech (Jiangsu) Introduction and Business Overview

Table 124. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 125. YC Biotech (Jiangsu) Mesalazine API Product Offerings

Table 126. YC Biotech (Jiangsu) Recent Development

Table 127. Xinxiang Tianfeng Fine Chemical Company Information

Table 128. Xinxiang Tianfeng Fine Chemical Introduction and Business Overview

Table 129. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 130. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Offerings

Table 131. Xinxiang Tianfeng Fine Chemical Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Mesalazine API Downstream Customers

Table 135. Mesalazine API Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Mesalazine API Product Picture

Figure 2. Global Mesalazine API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Mesalazine API Sales Volume (2019-2030) & (Tons)

Figure 5. Global Mesalazine API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Mesalazine API Report Years Considered

Figure 7. Global Mesalazine API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Mesalazine API Players Sales Volume Ranking (2023) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mesalazine API Revenue in 2023

Figure 10. Mesalazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Above 97 % Picture

Figure 12. Above 98 % Picture

Figure 13. Above 99 % Picture

Figure 14. Global Mesalazine API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Mesalazine API Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Mesalazine API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)

Figure 17. Global Mesalazine API Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Mesalazine API Price by Type (2019-2030) & (US$/Ton)

Figure 19. Product Picture of Tablets

Figure 20. Product Picture of Capsules

Figure 21. Product Picture of Granule

Figure 22. Product Picture of Suppository

Figure 23. Product Picture of Enema

Figure 24. Product Picture of Others

Figure 25. Global Mesalazine API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Mesalazine API Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Mesalazine API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)

Figure 28. Global Mesalazine API Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Mesalazine API Price by Application (2019-2030) & (US$/Ton)

Figure 30. North America Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Mesalazine API Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Mesalazine API Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Mesalazine API Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Mesalazine API Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Mesalazine API Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Mesalazine API Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Mesalazine API Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Mesalazine API Sales Volume (%), (2019-2030)

Figure 42. United States Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 48. China Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 50. China Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 60. India Mesalazine API Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Mesalazine API Sales Value by Type (%), 2023 VS 2030

Figure 62. India Mesalazine API Sales Value by Application (%), 2023 VS 2030

Figure 63. Mesalazine API Industrial Chain

Figure 64. Mesalazine API Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36O13443

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Tumor Marker Detection Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29Q13199

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Capsule Filling Machines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5E14004

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Gradient PCR Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21Q12960

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Mesalazine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-20G13067

Mesalazine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Mesalazine API - Market Size

Mesalazine API - Market

Report Scope

Scope of Mesalazine API - Market Report

Chapter Outline

FAQ for this report

What is the Mesalazine API - Market size in 2030?

Who are the main players in the Mesalazine API - Market report?

What are the Application segmentation covered in the Mesalazine API - Market report?

What are the Type segmentation covered in the Mesalazine API - Market report?

FEATURED COMPANIES

RELATED REPORTS